Stock listing

Argenx Se

Selected listing: A1RG34 · BMFBOVESPA · BRL · BR

Argenx Se (B3:A1RG34), Health Technology. Latest release Sep 17, 2026: Argenx announces results of Extraordinary General Meeting of Shareholders…

A1RG34:BMFBOVESPABRLBRUpdated October 3, 2026

Ticker: B3:A1RG34
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: B3
Currency: BRL

About Argenx Se

Argenx Se (ARGX) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.

Latest news from Argenx Se

Argenx announces results of Extraordinary General Meeting of Shareholders and appointment of Thomas M. Brakel and Khurem Farooq as Non-Executive Directors

September 17, 2026

Argenx : argenx to Present at Upcoming Investor Conferences

September 1, 2026

Argenx Completes Acquisition of Forte Biosciences, Inc.

August 27, 2026

Argenx : argenx Announces Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis

August 17, 2026

Argenx Announces Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis

August 17, 2026

All Argenx Se news →

Events

Replays

argenx SE (ARGX) Q2 2026 Earnings Call
Thu, Jul 23, 2026 · 09:30 AM ET
Watch
argenx SE (ARGX) Q1 2026 Earnings Call
Thu, May 07, 2026 · 08:30 AM ET
Watch
argenx SE (ARGX) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 08:30 AM ET
Watch

Research Argenx Se

Argenx Se company profile

View the public company page for Argenx Se on 6ix.

Argenx Se news

Read company news and market updates connected to Argenx Se.

Argenx Se investor events

Find investor webinars, events, and replay context for Argenx Se.